1users liked this postsusers disliked this posts0
BS...as I have posted before, this is a low priced short and trade stock. If any of the funds thought this company has an upside potential they would be buying until npsp had to issue more shares. this is not some cure for cancer stock or company, it is a dream that a few people will be helped with the short bowel problem.
unfortunately this stock has no great upside in the near future and will be returning to the 4 and 5 level
and possibly 3 like it was...i'm really disappointed npsp has fooled us once again.